opgn stock forecast zacks
Interested parties can register for or listen to the call. Searching for Financial Security.
Intuit Intu Surges 72 Ytd Will The Rise Continue In 2022 Nasdaq
OpGen - Full Company Report.
. Ad These 5 companies are set for historic price action. OpGen will be holding an earnings conference call on Tuesday March 29th at 430 PM Eastern. The brokerage presently has a 075 price target on the medical research companys stock.
CODX came out with quarterly earnings of 025 per share beating the Zacks Consensus Estimate of 015 per share. Common Stock OPGN. This suggests a possible upside of 3845 from the stocks current price.
Zacks Has More Than Doubled the SP 500 With an Average Gain of 2480 Per Year. OPGN Complete OpGen Inc. Ad Invest Like a Pro With Zacks.
Our Financial Advisors Offer a Wealth of Knowledge. OpGen NASDAQ Updated Mar 18 2022 455 PM. Get the latest Full Company Report for OpGen from Zacks Investment Research.
Join Free for Daily Newsletters Tools More. The average twelve-month price target for OpGen is 350 with a high price target of 400 and a low price target of 300. OPGN Earnings Information.
When you sign up youll reveal the names and ticker symbols of these 5 companies. Is a microbial genetics analysis company. Find a Dedicated Financial Advisor Now.
Read our earnings report guide before you consider the forecast information when. Find the latest OpGen Inc. OPGN 087 001 120.
Stock news by MarketWatch. 1 day agoCoDiagnostics Inc. The ABR is the calculated average of the actual recommendations.
An industry with a larger percentage of Zacks Rank 1s and 2s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank 4s and 5s. Zacks Investment Researchs price objective points to a potential. Zacks proprietary data indicates that OpGen Inc.
OpGen has confirmed that its next quarterly earnings report will be published on Tuesday March 29th 2022. Zacks provides the average brokerage recommendation ABR for thousands of stocks for most of the leading investment web sties. View real-time stock prices and stock quotes for a full financial overview.
View analysts price targets for OpGen or. This compares to earnings of 043 per share a year ago. The Company offers optical mapping services for analysis of microbial yeast and fungal genomic architecture.
OPGN stock quote history news and other vital information to help you with your stock trading and investing. The industry with the best average Zacks Rank would be considered the top industry 1 out of 265 which would place it in the top 1 of Zacks Ranked Industries. Zacks Investment Research is releasing its prediction for OPGN based on the 1-3 month trading system that nearly triples the SP 500.
Their forecasts range from 300 to 400. Click here - the OPGN analysis is free About Price and. The 2 analysts offering 12-month price forecasts for OpGen Inc have a median target of 350 with a high estimate of 400 and a.
According to the issued ratings of 2 analysts in the last year the consensus rating for OpGen stock is Buy based on the current 2 buy ratings for OPGN. Ad Ensure Your Investments Align with Your Goals. On average they expect OpGens share price to reach 350 in the next year.
Is currently rated as a Zacks Rank 2 and we are expecting an above average return from the OPGN shares. Learn more on OPGNs analyst rating history. Or dial in at 412-317-6671 with passcode 13726634.
Now is the time to move.
Rite Aid Rad Stock Dips 13 Ytd Can It Get Back On Track Nasdaq
Target Tgt To Invest 5b Plans To Add More Ulta Locations Nasdaq
Alset Ehome International Inc Shares Near 52 Week Low Market Mover Nasdaq
3 Reasons To Add Mckesson Mck Stock To Your Portfolio Nasdaq
Phillips 66 Psx Announces 2022 Spending Budget Of 1 9b Nasdaq
Is Lithia Motors Lad A Suitable Pick For Value Investors Now Nasdaq
Down 19 In 4 Weeks Here S Why Axsome Axsm Looks Ripe For A Turnaround Nasdaq
Here S Why You Should Retain Cvs Health Cvs Stock For Now Nasdaq
Vyne Therapeutics Inc Shares Close The Day 12 5 Lower Daily Wrap Nasdaq
Esperion Espr Q4 Earnings Beat Product Sales Rise 49 Nasdaq
What Makes Cf Industries Cf Stock A Solid Choice Right Now Nasdaq
Editas Edit Focuses On Developing Gene Editing Eye Drug Nasdaq
Pepsico Pep Q4 Earnings In Line Revenues Beat Estimates Nasdaq
Here S Why Acuity Brands Ayi Is A Great Buy The Bottom Stock Now Nasdaq
Enbridge Enb Receives Tsx Approval For Share Buyback Program Nasdaq
Zogenix Zgnx Stock Surges On Acquisition Offer From Ucb Nasdaq